Influenza Trials in Atlanta, United States
Conditions / Influenza / Atlanta, United States
Research into Influenza spans multiple therapeutic approaches and trial phases.
46 total trials for this combination
Showing top 10 of 46 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07159763 | A Study to Evaluate the Safety and Efficacy of CD388 for Prevention of Influenza | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT01046331 | Novel Influenza A (H1N1) Surveillance Registry | COMPLETED | — |
| NCT06020118 | Comparative Immunogenicity of Concomitant vs Sequential mRNA COVID-19 and Influenza Vaccinations | COMPLETED | PHASE4 |
| NCT02008344 | Phase 3 Efficacy and Safety Study of Favipiravir for Treatment of Uncomplicated Influenza in Adults | COMPLETED | PHASE3 |
| NCT02026349 | Phase 3 Efficacy and Safety Study of Favipiravir for Treatment of Uncomplicated Influenza in Adults - T705US316 | COMPLETED | PHASE3 |
| NCT00412737 | A Study of Oseltamivir (Tamiflu) for the Seasonal Prophylaxis of Influenza in Immunocompromised Participants | COMPLETED | PHASE4 |
| NCT00128167 | Trivalent, Live, Cold Adapted Influenza Vaccine (CAIV-T) Against Inactivated Influenza Vaccine (TIV) in Children 6-59 Months of Age | COMPLETED | PHASE3 |
| NCT05608005 | Study on Two Adjuvanted Dose Levels of Panblok H7+MF59 Compared for Immunogenicity and Safety With an Unadjuvanted Dose of Panblok H7 in Participants 18 Years of Age and Older | COMPLETED | PHASE1/PHASE2 |
| NCT06097273 | A Study of mRNA-1083 (SARS-CoV-2 and Influenza) Vaccine in Healthy Adult Participants, ≥50 Years of Age | COMPLETED | PHASE3 |
| NCT01050257 | A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza | COMPLETED | PHASE3 |